Partner
Charles Collins-Chase litigates in district courts and argues appeals at the U.S. Court of Appeals for the Federal Circuit, where he served as a clerk. With a chemical engineering background, he has particular expertise in pharmaceuticals, energy and renewables, and chemical products and has assisted numerous clients in Hatch-Waxman litigation. Charles handles cases in a wide array of technology areas, from polymers and pharmaceuticals to computer software and interactive toys.
Charles has handled district court cases at every stage of litigation, from pre-litigation through discovery, dispositive motions, and trial. He particularly enjoys writing briefs and motions. He has represented several branded pharmaceutical companies in Abbreviated New Drug Applications (ANDA) litigations under the Hatch-Waxman Act and also represents clients in the areas of clean energy and renewable materials.
Charles also has extensive experience in Federal Circuit appeals. He has argued before the Federal Circuit and has assisted clients in over a dozen district court and Patent Trial and Appeal Board (PTAB) appeals involving technologies ranging from polymers and pharmaceuticals to software and interactive toys. He has represented clients in numerous appeals involving patent eligibility under 35 U.S.C. § 101, including petitioners in the Bilski v. Kappos case before the U.S. Supreme Court. He also submitted a Federal Circuit amicus brief on behalf of Genetic Alliance in the Myriad Genetics case.
Charles has broad expertise in clean energy and renewable technologies. Charles has handled litigation, appeals, and due diligence matters for renewable industry clients. His work spans a wide range of technologies, ranging from renewable diesel fuel and other biofuels to pollution control systems and biobased polymers
Before law school, Charles completed graduate studies in engineering for sustainable development at the University of Cambridge and conducted research on the feasibility of biodiesel production using a novel reactor system in a community-scale project in South Africa. His undergraduate thesis involved synthesizing and characterizing thermosetting liquid-molding polymers made from soybean oil and other renewable resources.
Charles also devotes a portion of his time to pro bono matters. He argued before the Federal Circuit on behalf of a veteran seeking service-connected disability benefits. He also successfully represented a client seeking Social Security disability benefits, writing the briefs and arguing at a hearing before an administrative law judge.
Charles serves as an adjunct professor for the Federal Circuit Practice Seminar at George Mason University’s Antonin Scalia Law School.
Dialware Communications, LLC v. Hasbro, Inc.
Lead counsel for Dialware Communications in a Federal Circuit appeal from a district court decision invalidating five patents under 35 U.S.C. § 101.
17-1952, Fed. Cir.
Ferring B.V. v. Allergan, Inc.
Representing Ferring in an inventorship dispute relating to pharmaceutical formulations of desmopressin.
1:12-cv-02650, S.D.N.Y., Judges Cott, Sweet
Organik Kimya AS v. Rohm and Haas Co.
Represented appellant Organik Kimya in a Federal Circuit appeal from an IPR proceeding.
15-1983; 15-2001, Fed. Cir., Judges Prost, Newman, Taranto
5th Market, Inc. v. Chicago Mercantile Exchange, Inc.
Represented CME in two Federal Circuit appeals from covered business method (“CBM”) proceedings before the Patent Trial and Appeal Board.
15-1785, -1787; 16-1151, Fed. Cir.
Represented Bilski as petitioner; assisted with drafting and researching merits briefs and preparing for oral argument, resulting in a ruling that business methods are not per se patent ineligible.
08-964, S. Ct., Judges Alito, Breyer, Ginsburg, Kennedy, Roberts, Scalia, Souter, Stevens, Thomas
Association for Molecular Pathology v. Myriad Genetics, Inc.
Submitted amicus brief on behalf of Genetic Alliance regarding the patent eligibility under § 101 of isolated DNA molecules.
12-398, S. Ct., Judges Alito, Breyer, Ginsburg, Kagan, Kennedy, Roberts, Sotomayor, Thomas
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.